Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS)
Clinical trial NCT04313881 · TERMINATED
Trial details
- NCT number
- NCT04313881
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-09
- Primary completion
- 2023-09-13
- Enrollment
- 539
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.